|
Licenses and Collaborations (Details Narrative) (USD $)
|
Sep. 30, 2014
|
Dec. 31, 2013
|
Dec. 31, 2011
|
|---|---|---|---|
| Licenses And Collaborations Details Narrative | |||
| Additional exercisable options | $ 37,500,000 | ||
| Common stock purchased by Teva | 687,442 | ||
| Value of stock purchased by Teva | 7,500,000 | ||
| Liability, initial fair value of Teva options | 4,200,000 | ||
| Common stock issued | 123,000 | 3,100,000 | |
| Transaction costs | $ 172,000,000 |
| X | ||||||||||
|
- Definition
No authoritative reference available. No definition available.
|
| X | ||||||||||
|
- Definition
No authoritative reference available. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
No authoritative reference available. No definition available.
|
| X | ||||||||||
|
- Definition
For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of acquisition related costs. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Fair value portion of liability related to investment contracts for example, but not limited to, guaranteed investment contract or annuities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|